In this paper, we use an inhibitor of NADPH oxidase(s), targeted at their C-terminal dehydrogenase domain, called nanoshutter-1, NS1 [12,13] to impede the differentiation of tumor-associated “M2” macrophages from blood monocytes. Here, FMO5 is linked to neoplasm.